Latest news
Loading news…
FoRx Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Basel, Basel-Stadt, Switzerland Founded 2019 11-50 employees For Profit
FoRx Therapeutics is a biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress pathways.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
7
Patents
17
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 34
- Patents granted
- 17
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $202K
Company Info
- Founded
- 2019
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 31
- HQ
- Basel, Basel-Stadt, Switzerland
- Region
- Europe, Middle East, and Africa (EMEA)
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- 0.4
- Trend (30d)
- -0.3
- Trend (90d)
- -1.8
- Last leadership hire
- Feb 26, 2025
7
professional contacts at FoRx Therapeutics
Contact execs at FoRx Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to FoRx Therapeutics
Loading news…
FAQs about FoRx Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.